Valneva SE (VALN)
USD 6.81
(2.71%)
USD 6.81
(2.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 52.83 Million EUR | 31.67% |
| 2022 | 36.86 Million EUR | -76.98% |
| 2021 | 160.16 Million EUR | 185.91% |
| 2020 | 56.01 Million EUR | -26.51% |
| 2019 | 76.22 Million EUR | 9.52% |
| 2018 | 69.6 Million EUR | 17.35% |
| 2017 | 59.31 Million EUR | 16.33% |
| 2016 | 50.98 Million EUR | 62.39% |
| 2015 | 31.39 Million EUR | 58.74% |
| 2014 | 19.77 Million EUR | 41.92% |
| 2013 | 13.93 Million EUR | 281.85% |
| 2012 | -7.66 Million EUR | -316.44% |
| 2011 | 3.54 Million EUR | -57.82% |
| 2010 | 8.39 Million EUR | 488.48% |
| 2009 | -2.16 Million EUR | -421.1% |
| 2008 | 673 Thousand EUR | 182.37% |
| 2007 | -817 Thousand EUR | -150.97% |
| 2006 | 1.6 Million EUR | -36.79% |
| 2005 | 2.53 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 10.59 Million EUR | -33.1% |
| 2024 Q2 | 14.59 Million EUR | 37.75% |
| 2023 Q2 | 6.87 Million EUR | -47.21% |
| 2023 Q3 | 17.09 Million EUR | 148.64% |
| 2023 Q4 | 15.83 Million EUR | -7.4% |
| 2023 FY | 48.53 Million EUR | 31.67% |
| 2023 Q1 | 13.02 Million EUR | 226.31% |
| 2022 Q3 | 125.43 Million EUR | 245.44% |
| 2022 Q2 | -86.24 Million EUR | -1179.66% |
| 2022 Q1 | 7.98 Million EUR | -96.8% |
| 2022 FY | 36.86 Million EUR | -76.98% |
| 2022 Q4 | -10.31 Million EUR | -108.22% |
| 2021 FY | 160.16 Million EUR | 185.91% |
| 2021 Q1 | 8.56 Million EUR | -73.49% |
| 2021 Q2 | 4.15 Million EUR | -51.46% |
| 2021 Q3 | -102.46 Million EUR | -2564.21% |
| 2021 Q4 | 249.9 Million EUR | 343.9% |
| 2020 Q3 | -3.06 Million EUR | -184.23% |
| 2020 FY | 56.01 Million EUR | -26.51% |
| 2020 Q2 | 3.63 Million EUR | -84.3% |
| 2020 Q1 | 23.13 Million EUR | -18.08% |
| 2020 Q4 | 32.31 Million EUR | 1155.95% |
| 2019 FY | 76.22 Million EUR | 9.52% |
| 2019 Q2 | 8.79 Million EUR | -61.15% |
| 2019 Q1 | 22.62 Million EUR | -3.85% |
| 2019 Q3 | 16.57 Million EUR | 88.52% |
| 2019 Q4 | 28.24 Million EUR | 70.42% |
| 2018 Q4 | 23.53 Million EUR | 111.49% |
| 2018 FY | 69.6 Million EUR | 17.35% |
| 2018 Q1 | 19.04 Million EUR | 29.15% |
| 2018 Q3 | 11.12 Million EUR | -30.03% |
| 2018 Q2 | 15.9 Million EUR | -16.48% |
| 2017 Q2 | 14.29 Million EUR | -5.46% |
| 2017 FY | 59.31 Million EUR | 16.33% |
| 2017 Q4 | 14.74 Million EUR | -2.69% |
| 2017 Q3 | 15.15 Million EUR | 5.97% |
| 2017 Q1 | 15.12 Million EUR | 16.91% |
| 2016 Q1 | 10.82 Million EUR | -7.46% |
| 2016 Q2 | 17.12 Million EUR | 58.14% |
| 2016 Q3 | 10.1 Million EUR | -40.98% |
| 2016 Q4 | 12.93 Million EUR | 28.02% |
| 2016 FY | 50.98 Million EUR | 62.39% |
| 2015 FY | 31.39 Million EUR | 58.74% |
| 2015 Q4 | 11.69 Million EUR | 22.54% |
| 2015 Q3 | 9.54 Million EUR | 64.69% |
| 2015 Q2 | 5.79 Million EUR | 33.11% |
| 2015 Q1 | 4.35 Million EUR | -3.24% |
| 2014 Q2 | 6.5 Million EUR | 65.91% |
| 2014 Q1 | 3.92 Million EUR | 53.74% |
| 2014 Q3 | 4.84 Million EUR | -25.5% |
| 2014 FY | 19.77 Million EUR | 41.92% |
| 2014 Q4 | 4.5 Million EUR | -7.16% |
| 2013 Q3 | 7.2 Million EUR | 108.79% |
| 2013 Q4 | 2.55 Million EUR | -64.57% |
| 2013 FY | 13.93 Million EUR | 281.85% |
| 2013 Q2 | 3.44 Million EUR | 265.26% |
| 2013 Q1 | -2.08 Million EUR | -47.28% |
| 2012 FY | -7.66 Million EUR | -316.44% |
| 2012 Q3 | -1.52 Million EUR | 0.0% |
| 2012 Q4 | -1.41 Million EUR | 7.14% |
| 2011 FY | 3.54 Million EUR | -57.82% |
| 2010 FY | 8.39 Million EUR | 488.48% |
| 2009 FY | -2.16 Million EUR | -421.1% |
| 2008 FY | 673 Thousand EUR | 182.37% |
| 2007 FY | -817 Thousand EUR | -150.97% |
| 2006 FY | 1.6 Million EUR | -36.79% |
| 2005 FY | 2.53 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Dyadic International, Inc. | 922.95 Thousand USD | -5624.752% |
| Agenus Inc. | 139.61 Million USD | 62.155% |
| AlloVir, Inc. | -398 Thousand USD | 13375.628% |
| Ardelyx, Inc. | 106.66 Million USD | 50.463% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -163.5% |
| Chimerix, Inc. | 324 Thousand USD | -16207.716% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 269.525% |
| CRISPR Therapeutics AG | 240.95 Million USD | 78.072% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -218.737% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 153.826% |
| Fortress Biotech, Inc. | 57.85 Million USD | 8.67% |
| Fortress Biotech, Inc. | 57.85 Million USD | 8.67% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -150.876% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 36043.537% |
| IO Biotech, Inc. | -756 Thousand USD | 7089.021% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 5666.63% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 55.878% |
| MiMedx Group, Inc. | 266.84 Million USD | 80.199% |
| Senti Biosciences, Inc. | -2.68 Million USD | 2069.325% |
| Opthea Limited | 21.72 Thousand USD | -243164.273% |
| Pharming Group N.V. | 220.1 Million USD | 75.995% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -5136.571% |
| PureTech Health plc | -1.6 Million USD | 3396.132% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 51.867% |
| Elevation Oncology, Inc. | -39 Thousand USD | 135579.487% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 216.574% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 10125.996% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 153.796% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1440.344% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 92269.347% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 440408.333% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -81.39% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1106.875% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 49.244% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 60.939% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -571.287% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 50.39 Million USD | -4.846% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -79.797% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 22874.569% |
| Vaxxinity, Inc. | -2.23 Million USD | 2465.13% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 10839.228% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -145.24% |
| Aptorum Group Limited | -1.11 Million USD | 4840.071% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 149.788% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 96167.273% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 56.142% |
| ContextLogic Inc. | 59 Million USD | 10.446% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -43930.833% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 154.499% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 44691.572% |
| Pyxis Oncology, Inc. | -2 Million USD | 2741.85% |
| Royalty Pharma plc | 1.79 Billion USD | 97.055% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -8576.026% |
| TG Therapeutics, Inc. | 219.1 Million USD | 75.885% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 119673.187% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 212.806% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 10324.946% |
| Seer, Inc. | 7.02 Million USD | -651.914% |
| MEI Pharma, Inc. | 49.32 Million USD | -7.116% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 525788.986% |
| NextCure, Inc. | -3.68 Million USD | 1534.229% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 282.398% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -10552.621% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -10159.612% |
| AnaptysBio, Inc. | 14.78 Million USD | -257.466% |
| ChromaDex Corporation | 50.78 Million USD | -4.051% |
| Precigen, Inc. | 106 Thousand USD | -49746.226% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 1531.121% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 168.091% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 340.31% |
| Acelyrin, Inc. | -115 Thousand USD | 46045.217% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 9353.415% |
| Psyence Biomedical Ltd. | -240.00 USD | 22015516.667% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 8057.38% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 30319.683% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -6488.155% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 3155.928% |
| AbCellera Biologics Inc. | 38.02 Million USD | -38.953% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 96.519% |
| Bicycle Therapeutics plc | -129.52 Million USD | 140.794% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 36971.341% |
| Incyte Corporation | 3.44 Billion USD | 98.464% |
| Alkermes plc | 1.37 Billion USD | 96.156% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -1952.72% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -177.462% |
| Onconetix, Inc. | -1.12 Million USD | 4787.601% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 129.126% |
| Geron Corporation | -123.5 Million USD | 142.782% |
| Summit Therapeutics Inc. | -2.05 Million USD | 2677.415% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1204.295% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1201.23% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 64535.366% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 495.55% |
| Innoviva, Inc. | 261.06 Million USD | 79.761% |
| Jaguar Health, Inc. | 7.72 Million USD | -584.063% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1056840.0% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -81.852% |
| Vaxcyte, Inc. | -75 Million USD | 170.449% |
| ADMA Biologics, Inc. | 88.21 Million USD | 40.106% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 78.052% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -12361.557% |
| Novavax, Inc. | 639.93 Million USD | 91.743% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 330.538% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 104232.834% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 2895.608% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 83.155% |
| Precision BioSciences, Inc. | 40.47 Million USD | -30.552% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| ImmuCell Corporation | 4.39 Million USD | -1101.856% |
| Immix Biopharma, Inc. | -5468.00 USD | 966394.806% |
| Mesoblast Limited | -9.81 Million USD | 638.329% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 844.393% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 11234.244% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 508148.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -54197.048% |
| Century Therapeutics, Inc. | -10.8 Million USD | 588.824% |
| Kura Oncology, Inc. | -849 Thousand USD | 6323.439% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 178.739% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 46.65% |
| Autolus Therapeutics plc | -4.86 Million USD | 1185.617% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -27.669% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 31550.595% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 44.219% |
| GRI Bio, Inc. | 10.84 Million USD | -387.381% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -1980.208% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 708.231% |
| IGM Biosciences, Inc. | -211.66 Million USD | 124.963% |
| INmune Bio, Inc. | 155 Thousand USD | -33988.387% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 14.695% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3607.755% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 8248.149% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 180591.221% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -13043.532% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 2747.144% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 16980.831% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 44.065% |
| Verastem, Inc. | -62 Thousand USD | 85320.968% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -2069.897% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 20344.061% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -1645.524% |
| Histogen Inc. | 3.76 Million USD | -1301.884% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -9070.24% |
| Surrozen, Inc. | -27.23 Million USD | 294.04% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1080.46% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 4485.25% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 306.016% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 2668635.354% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -770.975% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 78807.304% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 65.866% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -36139.369% |
| Apollomics, Inc. | 127 Thousand USD | -41503.937% |
| Amarin Corporation plc | 165.54 Million USD | 68.082% |
| Turnstone Biologics Corp. | 16.5 Million USD | -220.108% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 147.821% |
| Synaptogenix, Inc. | -6347.00 USD | 832572.034% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 103701.961% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 67.256% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 96.994% |
| Better Therapeutics, Inc. | -2.72 Million USD | 2036.13% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 147.108% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 84.371% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 463257.433% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 944.042% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4868.682% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -622.014% |
| Insmed Incorporated | 239.63 Million USD | 77.951% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -1376.719% |
| OmniAb, Inc. | 14.66 Million USD | -260.244% |
| Alector, Inc. | -95.05 Million USD | 155.587% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 57.939% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 221.568% |
| Zai Lab Limited | 170.9 Million USD | 69.084% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 35.468% |
| Aura Biosciences, Inc. | -1.29 Million USD | 4180.077% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -40543.846% |
| Immunic, Inc. | -111 Thousand USD | 47700.901% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -233.272% |
| Veracyte, Inc. | 248.14 Million USD | 78.707% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.756% |
| FibroGen, Inc. | 128.9 Million USD | 59.011% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 9368362.411% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 552.88% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 98.445% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -13482.776% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 85.131% |
| Galecto, Inc. | -830 Thousand USD | 6465.904% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 3914.946% |
| Fortrea Holdings Inc. | 424 Million USD | 87.538% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 161.319% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 9418.695% |
| XBiotech Inc. | -1.74 Million USD | 3129.644% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4868.682% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 213.699% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 169.951% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 28.018% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -214.45% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 86.419% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 206.425% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 83.83% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 566.6% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -116.093% |
| NexImmune, Inc. | -1.02 Million USD | 5254.97% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -978362.963% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 843.591% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.532% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 79165.348% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 1587.947% |
| Ainos, Inc. | -253.73 Thousand USD | 20923.858% |
| Pluri Inc. | 322 Thousand USD | -16309.006% |
| Prothena Corporation plc | -129.2 Million USD | 140.895% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -4.786% |
| Celularity Inc. | 6.75 Million USD | -682.191% |
| Rallybio Corporation | -150 Thousand USD | 35324.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 262.042% |
| MeiraGTx Holdings plc | 287 Thousand USD | -18310.105% |
| Omeros Corporation | -69.77 Million USD | 175.72% |
| Humacyte, Inc. | -76.55 Million USD | 169.023% |
| Immunocore Holdings plc | 248.39 Million USD | 78.728% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 448.322% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 15.301% |
| Blueprint Medicines Corporation | 236.58 Million USD | 77.667% |
| CalciMedica, Inc. | -58 Thousand USD | 91198.276% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 3805.259% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 1957.841% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 271.187% |
| Pulmatrix, Inc. | -8.22 Million USD | 742.786% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 4615.983% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 13342.356% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 113.249% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -1803.635% |
| Cytokinetics, Incorporated | -322.59 Million USD | 116.379% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -6028.836% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 15594.721% |
| Vor Biopharma Inc. | -3.49 Million USD | 1613.087% |
| Roivant Sciences Ltd. | 109.23 Million USD | 51.63% |
| Evogene Ltd. | 1.39 Million USD | -3676.769% |
| ProKidney Corp. | -3.16 Million USD | 1767.308% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 220.325% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -670.556% |
| CorMedix Inc. | -205.56 Thousand USD | 25803.681% |
| BioLineRx Ltd. | 1.1 Million USD | -4668.682% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 167.162% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 160212.121% |
| Atai Life Sciences N.V. | -5000.00 USD | 1056840.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 43459.128% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 55138.542% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 3903.96% |
| Sagimet Biosciences Inc. | 2 Million USD | -2541.85% |
| MediciNova, Inc. | 979.7 Thousand USD | -5293.154% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 162.663% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 55979.647% |
| GeoVax Labs, Inc. | -20.72 Million USD | 354.995% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 78.393% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1357.724% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 93.943% |
| Mereo BioPharma Group plc | 7.42 Million USD | -611.514% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 17144.194% |
| Absci Corporation | -41.84 Million USD | 226.256% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1056840.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 169.183% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 2246.973% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 75.279% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 5714.984% |
| Allakos Inc. | -6.14 Million USD | 960.397% |
| Imunon, Inc. | -720 Thousand USD | 7438.421% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 176.58% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 88.897% |
| BioAtla, Inc. | -103.73 Million USD | 150.937% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 463257.433% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 29783.708% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 121.76% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 17089.389% |
| XOMA Corporation | 3.86 Million USD | -1268.48% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 175.39% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -257.152% |
| aTyr Pharma, Inc. | -2.38 Million USD | 2312.605% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -324.053% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 182296.552% |
| Viridian Therapeutics, Inc. | -1 Million USD | 5341.766% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -406438361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 1321025.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 91.704% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -27036.533% |
| UroGen Pharma Ltd. | 73.35 Million USD | 27.968% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 297.936% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -454999.053% |
| Orgenesis Inc. | -5.72 Million USD | 1022.917% |
| Entera Bio Ltd. | -56 Thousand USD | 94451.786% |
| GH Research PLC | -315 Thousand USD | 16873.651% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 28056.085% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 10164.19% |
| Xencor, Inc. | -85.26 Million USD | 161.972% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 24010.633% |
| Replimune Group, Inc. | -2.65 Million USD | 2090.094% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 5377.177% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 70.29% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -27036.533% |
| Portage Biotech Inc. | -54 Thousand USD | 97946.296% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 55979.647% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 14115.119% |
| OncoCyte Corporation | 413 Thousand USD | -12693.462% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1175561.624% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 23800550.45% |
| Purple Biotech Ltd. | -196 Thousand USD | 27057.653% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -489.173% |
| scPharmaceuticals Inc. | 9.78 Million USD | -440.145% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 605.861% |
| HilleVax, Inc. | -2.15 Million USD | 2550.696% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 54571.134% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 352252.759% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 8009.731% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 229826.087% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 704015.184% |
| Savara Inc. | -44.26 Million USD | 219.373% |
| Curis, Inc. | 9.81 Million USD | -438.549% |
| Daré Bioscience, Inc. | 2.76 Million USD | -1807.802% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 42441.411% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 23274.123% |
| BeiGene, Ltd. | 2.07 Billion USD | 97.458% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 1989.803% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 113.22% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 6.793% |
| Erasca, Inc. | -3.73 Million USD | 1515.782% |
| bluebird bio, Inc. | -4.03 Million USD | 1411.092% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 187345.73% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 97.225% |
| DBV Technologies S.A. | 15.72 Million USD | -235.942% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 187345.73% |
| Moderna, Inc. | 2.15 Billion USD | 97.548% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 5874.536% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -559.968% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 9957.649% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 60.507% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 949.196% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 234.298% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 147.546% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 1572.603% |
| MacroGenics, Inc. | 50.52 Million USD | -4.572% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 966.464% |
| Prime Medicine, Inc. | -147.9 Million USD | 135.724% |
| Aditxt, Inc. | -111.66 Thousand USD | 47419.541% |
| Adagene Inc. | 18.11 Million USD | -191.732% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -10727.254% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 62.314% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 66.524% |
| SciSparc Ltd. | 2.19 Million USD | -2306.056% |
| Vericel Corporation | 135.57 Million USD | 61.028% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 211034.568% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 170640.959% |
| Generation Bio Co. | -73.91 Million USD | 171.487% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 12190.847% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 3.263% |
| Invivyd, Inc. | -2.02 Million USD | 2705.375% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 117.563% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 51180.841% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 45.172% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 46.243% |
| Clene Inc. | 533 Thousand USD | -9813.133% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -119.157% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 5621.108% |
| GeoVax Labs, Inc. | -20.72 Million USD | 354.995% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -2557.797% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 27291.276% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -6.088% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 845.023% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 6420.215% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 36.658% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -72168.574% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 0.611% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 130.508% |
| Trevena, Inc. | 1.45 Million USD | -3531.409% |
| Surrozen, Inc. | -27.23 Million USD | 294.04% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 15067.989% |
| Cingulate Inc. | -582.91 Thousand USD | 9164.225% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 170541.935% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 368.222% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 698078.864% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 6097.389% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 92.238% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 5447.874% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 93879.064% |
| Kronos Bio, Inc. | 1.37 Million USD | -3751.093% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 198.455% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 18194.863% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 10920.292% |
| ImmunityBio, Inc. | -17.89 Million USD | 395.344% |
| Korro Bio, Inc. | -3.63 Million USD | 1555.565% |
| Kineta, Inc. | 5.43 Million USD | -872.52% |
| BioVie Inc. | -229.37 Thousand USD | 23135.004% |
| Codexis, Inc. | 57.33 Million USD | 7.844% |
| Celularity Inc. | 6.75 Million USD | -682.191% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1216.646% |
| Celcuity Inc. | -142.77 Thousand USD | 37107.957% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -104341.589% |
| Cibus, Inc. | 1.42 Million USD | -3615.682% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 14227.54% |
| IN8bio, Inc. | -2.5 Million USD | 2212.635% |
| Kodiak Sciences Inc. | -25.94 Million USD | 303.634% |
| Annexon, Inc. | -3.26 Million USD | 1717.294% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 2684.98% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 226.595% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -8155.781% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 93.213% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 69.45% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 2880.895% |
| Arcellx, Inc. | 108.27 Million USD | 51.203% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 263.233% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 33.29% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 349.797% |
| Moolec Science SA | -143.3 Thousand USD | 36970.312% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 224.857% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -1507.454% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 175.385% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 1462918.383% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -22734.51% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 147.424% |
| Humacyte, Inc. | -76.55 Million USD | 169.023% |
| 89bio, Inc. | -273 Thousand USD | 19454.212% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 4303.421% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 6330.778% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 43056.911% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -4621.805% |
| Notable Labs, Ltd. | 113 Thousand USD | -46658.407% |
| Liquidia Corporation | 14.6 Million USD | -261.897% |
| Mustang Bio, Inc. | -2.22 Million USD | 2474.697% |
| Immunovant, Inc. | -231 Thousand USD | 22973.16% |
| Quantum-Si incorporated | 488 Thousand USD | -10727.254% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 195.101% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 176223.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -2737.648% |
| Acasti Pharma Inc. | -11 Thousand USD | 480436.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 25922.39% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 8248.149% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 131.542% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -4556.966% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 13967.979% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 2798.519% |
| PepGen Inc. | -1.18 Million USD | 4562.584% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 41703.937% |
| United Therapeutics Corporation | 2.07 Billion USD | 97.447% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 330.759% |
| Solid Biosciences Inc. | -76.56 Million USD | 169.011% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 64080.48% |
| Immuneering Corporation | -764.13 Thousand USD | 7014.589% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -79637.112% |
| Belite Bio, Inc | -399 Thousand USD | 13342.356% |
| XOMA Corporation | 3.86 Million USD | -1268.48% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 363.71% |
| Bionomics Limited | -434.44 Thousand USD | 12261.842% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 5019.646% |
| uniQure N.V. | 2.21 Million USD | -2285.418% |
| Cassava Sciences, Inc. | -89.42 Million USD | 159.087% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 157.388% |
| Forte Biosciences, Inc. | -9000.00 USD | 587177.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 6427.784% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 12190.847% |
| Altimmune, Inc. | -65.37 Million USD | 180.824% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 85.405% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 5019.646% |
| Compugen Ltd. | 31.45 Million USD | -67.976% |
| Peak Bio, Inc. | 367.76 Thousand USD | -14266.899% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -115.52% |
| Benitec Biopharma Inc. | 108 Thousand USD | -48823.148% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 67839.744% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 4492.103% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 2999.945% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 44500.84% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 4492.103% |
| Instil Bio, Inc. | -4.75 Million USD | 1210.955% |
| argenx SE | 1.1 Billion USD | 95.233% |
| Immunome, Inc. | -8.9 Million USD | 693.208% |
| Verona Pharma plc | -679.62 Thousand USD | 7874.446% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 30292.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 2315.388% |
| CervoMed Inc. | -1.29 Million USD | 4184.408% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 2295.139% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1206.071% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -2038.284% |
| Moolec Science SA | -143.3 Thousand USD | 36970.312% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 13049.293% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 2077.782% |
| Design Therapeutics, Inc. | -537 Thousand USD | 9939.292% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 12474.005% |
| NeurAxis, Inc. | 2.15 Million USD | -2349.896% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -2362.116% |
| Lumos Pharma, Inc. | 2 Million USD | -2532.636% |
| Achilles Therapeutics plc | -4.73 Million USD | 1216.762% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 30292.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 50099.527% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -66.895% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -6028.836% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 5219.864% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 216.003% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -122776.744% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 6527.859% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 401657.988% |
| Palisade Bio, Inc. | 246 Thousand USD | -21378.455% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 160212.121% |
| Beam Therapeutics Inc. | -59.67 Million USD | 188.546% |
| Neurogene Inc. | -3.26 Million USD | 1719.773% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 62.079% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -32.093% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 17890.236% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 1412.056% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 652.342% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -275.263% |
| Athira Pharma, Inc. | -969 Thousand USD | 5552.735% |
| Vaccinex, Inc. | -16 Million USD | 430.149% |
| HCW Biologics Inc. | -574.82 Thousand USD | 9291.857% |
| XOMA Corporation | 3.86 Million USD | -1268.48% |
| Nektar Therapeutics | 53.47 Million USD | 1.199% |
| Arvinas, Inc. | 71.8 Million USD | 26.411% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 163.307% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 184.169% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 16509.006% |
| Rezolute, Inc. | -36 Thousand USD | 146869.444% |
| Clene Inc. | 533 Thousand USD | -9813.133% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 4115131.153% |
| BeyondSpring Inc. | 1.75 Million USD | -2917.533% |
| Synlogic, Inc. | -1.92 Million USD | 2846.206% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 142902.703% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 934.444% |
| Peak Bio, Inc. | 367.76 Thousand USD | -14266.899% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 378.632% |
| Krystal Biotech, Inc. | 47.6 Million USD | -10.99% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 62.551% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -951.483% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 2140.654% |
| MannKind Corporation | 136.19 Million USD | 61.204% |
| Ikena Oncology, Inc. | -50.49 Million USD | 204.644% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 51.443% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1304.949% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 21067.063% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1056840.0% |
| Legend Biotech Corporation | 140.92 Million USD | 62.508% |
| Mural Oncology plc | -2.56 Million USD | 2158.317% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 9689.292% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 52937.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -154.587% |
| REGENXBIO Inc. | 53.02 Million USD | 0.362% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1086.326% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 27565.627% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 3150.635% |
| Vaxart, Inc. | -60.76 Million USD | 186.956% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 20206.934% |
| Cellectis S.A. | 18 Thousand USD | -293438.889% |
| Longeveron Inc. | 221 Thousand USD | -23808.145% |
| Repare Therapeutics Inc. | -80.07 Million USD | 165.989% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 95.166% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 4183.23% |
| Revolution Medicines, Inc. | -399.66 Million USD | 113.22% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 151062.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -107730.612% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.386% |
| Denali Therapeutics Inc. | -93.34 Million USD | 156.604% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 211034.568% |
| Veru Inc. | 7.56 Million USD | -598.355% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 35091.391% |
| Cingulate Inc. | -582.91 Thousand USD | 9164.225% |
| Passage Bio, Inc. | -3.72 Million USD | 1519.968% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 438799.768% |
| Exicure, Inc. | -1.42 Million USD | 3813.071% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 13895.561% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -1854.754% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 10406.139% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 22.442% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 35417.198% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 189.243% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -13413.299% |
| OmniAb, Inc. | 14.66 Million USD | -260.244% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -164.277% |
| Lipocine Inc. | -2.85 Million USD | 1953.398% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 2966.902% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1026.152% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3607.755% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 29.846% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 81387.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 37.32% |
| Ocugen, Inc. | -33.53 Million USD | 257.548% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 1770.999% |
| Q32 Bio Inc. | 578 Thousand USD | -9041.349% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 20038.491% |
| Alumis Inc. Common Stock | -1.28 Million USD | 4215.031% |
| Equillium, Inc. | 35.95 Million USD | -46.941% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 3195.313% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -10453.069% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1278208.37% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 20500.386% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -12399.527% |
| Dominari Holdings Inc. | 2.03 Million USD | -2491.319% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 28898.557% |
| vTv Therapeutics Inc. | -13.59 Million USD | 488.65% |
| Bio-Techne Corporation | 773.07 Million USD | 93.165% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -205.081% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 88.533% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 4619.846% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 320.338% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -351.714% |
| Nkarta, Inc. | -5.86 Million USD | 1000.273% |
| BioCardia, Inc. | -7.24 Million USD | 828.887% |
| Iterum Therapeutics plc | -1.75 Million USD | 3119.257% |